Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier
US9839207B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 1, 2015 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Oct 1, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4703
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a HSP27 mutation (S135F) mediated Charcot-Marie-Tooth disease (CMT) animal model. Particularly, the vector expressing mutant HSP27 protein wherein the 135th serine is substituted with phenylalanine has been injected in the mouse zygote and then the mouse harboring the expression vector was selected. The selected mouse was confirmed to display Charcot-Marie-Tooth disease phenotype, so that the animal model was expected to be efficiently used for the evaluation of the effect of Charcot-Marie-Tooth disease treating material candidates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.